Skip to content

Clinical trials

Lung Diseases trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Not applicable Clear all

341 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20024
20035
20045
20052
20063
20072
20085
20099
20105
20116
20129
201313
201413
201512
201615
201718
201821
201925
202029
202123
202221
202329
202425
202517
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed202
Unknown status52
Recruiting36
Terminated16
Withdrawn14
Active, not recruiting10
Not yet recruiting9
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris6
Medipol University6
Riphah International University6
VA Office of Research and Development6
National Heart, Lung, and Blood Institute (NHLBI)5
University of California, San Francisco5
Johns Hopkins University4
Medical University of Vienna4
NYU Langone Health4
National Taiwan University Hospital4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases341
Pulmonary Disease, Chronic Obstructive65
Respiratory Tract Diseases28
Asthma26
Lung Neoplasms26
Dyspnea20
Heart Diseases16
Neoplasms14
Cystic Fibrosis13
Lung Diseases, Obstructive11

Trials

Showing 1 to 25 of 341. Each trial links to its page on Pharma Observatory.

241 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.